Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Migraine Without Aura: early-phase trial registry

2 of 7 indexed Migraine Without Aura trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 2 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Migraine Without Aura: 7 US clinical trials tracked, 2 recruiting.

Migraine Without Aura is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Hospital Medical Center, Cincinnati, running 2 of these trials.

Enrollment posture brief

Registry condition migraine-without-aura

OPEN 2 | RECR 29% | LATE 1 | EARLY 2 | RANK #2497 | SPON 2

Nearest open-share peer: Acromegaly (29% recruiting · 14 trials)

ACL Tear71.4%ACL57.1%Acute Myelogenous Leukemia42.9%Migraine Without Aura (this)29%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Migraine Without Aura

Migraine Without Aura lists 2 open slots (29% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Migraine Without Aura on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Migraine Without Aura is recruiting below its size-band peers.

    2 of 7 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Migraine Without Aura research.

    Children's Hospital Medical Center, Cincinnati accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Migraine Without Aura enrolment sits around 61 participants.

    Median target enrolment is 61 among the 7 trials that report a genuine target (sentinel values excluded). 4 of those (57.1%) plan for fewer than 100 participants.

  4. Migraine Without Aura research is mostly interventional.

    7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 31

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 1

Named interventions

Most-linked intervention names on Migraine Without Aura records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Landmark-Based Greater Occipital Nerve Block Procedure
1 trials
Ultrasound Guided Greater Occipital Nerve Block at C2 Procedure
1 trials
Dihydroergotamine Drug
1 trials
NXN-188 Drug
1 trials
Placebo + Placebo Drug
1 trials
Maxalt 10mg MLT plus Placebo Drug
1 trials
Maxalt 10mg MLT plus Caffeine 75mg Drug
1 trials
Chiropractic Treatment Other
1 trials

US sites by state

Facility locations filed on Migraine Without Aura trials. A trial with sites in several states counts in each.

Ohio 2 trials
New York 2 trials
Georgia 2 trials
Florida 2 trials
Colorado 2 trials
West Virginia 1 trials
Utah 1 trials
Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Migraine Without Aura page

7 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Migraine Without Aura condition card totals 7 registered trials; most-linked intervention Landmark-Based Greater Occipital Nerve Block; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.